My Cart

ALCAM

ALCAM Overview

English NameActivated leukocyte cell adhesion moleculeApproved Drugs0
Drugs in Clinical Trials1Target SynonymCD166 antigen,Activated leukocyte cell adhesion molecule,CD166,ALCAM,MEMD,Activated Leucocyte Cell Adhesion Molecule,Activated-Leukocyte Cell Adhesion Molecule
Highest Development StagePhase 2 Clinical
English NameActivated leukocyte cell adhesion molecule
Target SynonymCD166 antigen,Activated leukocyte cell adhesion molecule,CD166,ALCAM,MEMD,Activated Leucocyte Cell Adhesion Molecule,Activated-Leukocyte Cell Adhesion Molecule
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 2 Clinical

ALCAM Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (2)

  • Tag

    Fc Tag (1)His Tag (1)

  • Conjugate

    Unconjugated (2)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeatureOrder Now
CD6-H5228
Human
HEK293
Human ALCAM Protein, His Tag
Add to Cart
CD6-H5259
Human
HEK293
Human ALCAM Protein, Fc Tag
Add to Cart
Total: 2
  • 1

ALCAM Background

CD166 antigen is a 100-105 kD typeI transmembrane glycoprotein that is a member of the immunoglobulin superfamily of proteins, which is also known as Activated leukocyte cell adhesion molecule (ALCAM) in human, SC-1/DM-GRASP/BEN in the chicken, and KG-CAM in the rat. CD166 is a cell adhesion molecule that binds to CD6. CD166 involved in neurite extension by neurons via heterophilic and homophilic interactions.

ALCAM Synonyms

CD166,ALCAM,CD6L,KG-CAM,MEMD

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Praluzatamab ravtansineCX-2009Phase 2 ClinicalImmunogen Inc, Cytomx Therapeutics IncSolid tumours; Ovarian Neoplasms; Head and Neck Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland